Cevoglitazar (LBM-642) is an orally active and highly potent PPARalpha and PPARgamma dual agonist. Cevoglitazar can reduce food intake, body weight, and fasting plasma insulin in obese mice and cynomolgus monkeys. Cevoglitazar has the potential for diabetes and obesity-related disorders research[1].
Molecular Weight:
558.53
CAS Number:
[839673-52-8]
Formula:
C27H21F3N2O6S
Target:
PPAR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
